289 related articles for article (PubMed ID: 19560747)
21. Primary Central Nervous System Lymphoma.
Sinicrope K; Batchelor T
Neurol Clin; 2018 Aug; 36(3):517-532. PubMed ID: 30072069
[TBL] [Abstract][Full Text] [Related]
22. [Primary intraocular lymphoma].
Coupland SE; Heimann H
Ophthalmologe; 2004 Jan; 101(1):87-98. PubMed ID: 14986704
[TBL] [Abstract][Full Text] [Related]
23. Intraocular lymphoma: update on diagnosis and management.
Chan CC; Wallace DJ
Cancer Control; 2004; 11(5):285-95. PubMed ID: 15377987
[TBL] [Abstract][Full Text] [Related]
24. Primary central nervous system lymphoma.
Schaff LR; Grommes C
Blood; 2022 Sep; 140(9):971-979. PubMed ID: 34699590
[TBL] [Abstract][Full Text] [Related]
25. Management of primary intraocular lymphoma.
Kim SK; Chan CC; Wallace DJ
Curr Oncol Rep; 2005 Jan; 7(1):74-9. PubMed ID: 15610690
[TBL] [Abstract][Full Text] [Related]
26. Recurrent primary central nervous system lymphoma complicated by lymphomatous meningitis.
Chamberlain MC; Kormanik P; Glantz M
Oncol Rep; 1998; 5(2):521-5. PubMed ID: 9468593
[TBL] [Abstract][Full Text] [Related]
27. Ocular manifestations and treatment of central nervous system lymphomas.
Gündüz K; Pulido JS; McCannel CA; O'Neill BP
Neurosurg Focus; 2006 Nov; 21(5):E9. PubMed ID: 17134125
[TBL] [Abstract][Full Text] [Related]
28. Treatment Options for Recurrent Primary CNS Lymphoma.
Kaulen LD; Baehring JM
Curr Treat Options Oncol; 2022 Nov; 23(11):1548-1565. PubMed ID: 36205806
[TBL] [Abstract][Full Text] [Related]
29. Analysis of Key Factors Associated with Response to Salvage High-Dose Methotrexate Rechallenge in Primary Central Nervous System Lymphoma with First Relapse.
Du P; Chen H; Shen L; Liu X; Wu X; Chen L; Cao A; Geng D
Curr Oncol; 2022 Sep; 29(9):6642-6656. PubMed ID: 36135091
[TBL] [Abstract][Full Text] [Related]
30. Current and emerging therapies for primary central nervous system lymphoma.
Yuan Y; Ding T; Wang S; Chen H; Mao Y; Chen T
Biomark Res; 2021 May; 9(1):32. PubMed ID: 33957995
[TBL] [Abstract][Full Text] [Related]
31. Characteristics and Outcomes of Primary Central Nervous System Lymphoma: A Retrospective Study of 91 Cases in a Chinese Population.
Mao C; Chen F; Li Y; Jiang X; Liu S; Guo H; Huang L; Wei X; Liang Z; Li W; Tang K
World Neurosurg; 2019 Mar; 123():e15-e24. PubMed ID: 30326304
[TBL] [Abstract][Full Text] [Related]
32. Radiotherapy or chemotherapy: a real-world study of the first-time relapsed and refractory primary central nervous system lymphoma.
Yang Y; Li Q; Ma J; Kang H; Lin Z; Wang Y; Ma Y; Chen B
Front Oncol; 2023; 13():1098785. PubMed ID: 37182159
[TBL] [Abstract][Full Text] [Related]
33. [Special hematological diagnostics and therapy options for ocular lymphoma taking CNS involvement into account].
Korfel A; Schlegel U; Schroers R
Ophthalmologe; 2015 Mar; 112(3):231-6. PubMed ID: 25721677
[TBL] [Abstract][Full Text] [Related]
34. Diagnosis and treatment of primary CNS lymphoma.
Korfel A; Schlegel U
Nat Rev Neurol; 2013 Jun; 9(6):317-27. PubMed ID: 23670107
[TBL] [Abstract][Full Text] [Related]
35. Treatment outcome of relapsed/refractory primary central nervous system diffuse large B-cell lymphoma: a single-center experience of autologous stem cell transplantation.
Choi MK; Kang ES; Kim DW; Ko YH; Seok H; Park JH; Pyo DH; Hoon Lim D; Kim SJ; Kim WS
Int J Hematol; 2013 Sep; 98(3):346-54. PubMed ID: 23868695
[TBL] [Abstract][Full Text] [Related]
36. Primary central nervous system lymphoma: a profile of 26 cases from Western India.
Agarwal PA; Menon S; Smruti BK; Singhal BS
Neurol India; 2009; 57(6):756-63. PubMed ID: 20139505
[TBL] [Abstract][Full Text] [Related]
37. Therapeutic management of refractory or relapsed primary central nervous system lymphomas.
Reni M; Ferreri AJ
Ann Hematol; 2001; 80 Suppl 3():B113-7. PubMed ID: 11757691
[TBL] [Abstract][Full Text] [Related]
38. Platine and cytarabine-based salvage treatment for primary central nervous system lymphoma.
del Rio MS; Choquet S; Hoang-Xuan K; Glaisner S; Fourme E; Janvier M; Soussain C
J Neurooncol; 2011 Nov; 105(2):409-14. PubMed ID: 21656329
[TBL] [Abstract][Full Text] [Related]
39. Primary CNS lymphoma with intraocular involvement: International PCNSL Collaborative Group Report.
Grimm SA; McCannel CA; Omuro AM; Ferreri AJ; Blay JY; Neuwelt EA; Siegal T; Batchelor T; Jahnke K; Shenkier TN; Hall AJ; Graus F; Herrlinger U; Schiff D; Raizer J; Rubenstein J; Laperriere N; Thiel E; Doolittle N; Iwamoto FM; Abrey LE
Neurology; 2008 Oct; 71(17):1355-60. PubMed ID: 18936428
[TBL] [Abstract][Full Text] [Related]
40. High-dose chemotherapy with thiotepa, busulfan, and cyclophosphamide and autologous stem cell transplantation for patients with primary central nervous system lymphoma in first complete remission.
DeFilipp Z; Li S; El-Jawahri A; Armand P; Nayak L; Wang N; Batchelor TT; Chen YB
Cancer; 2017 Aug; 123(16):3073-3079. PubMed ID: 28369839
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
